circana glp-1 Sally Lyons Wyatt, Global EVP & Chief Advisor, Consumer Goods & Foodservice Insights at Circana, explains how is reshaping snacking habits. While households using GLP-1 are buying fewer items cpg #glp1 #foodservice #retail #foodandbeverage

Semaglutide Semaglutide is a GLP-1 receptor agonist that specifically targets appetite, resulting in consistent, impressive fat loss over time

The defining feature of this molecule is the unusual gamma-peptide linkage between glutamate and cysteine, which protects the compound from being rapidly degraded by standard intracellular peptidases

Pricing is based on a 3-month plan

[1] Its the same method used for nicotine and birth control patches

Its also approved to reduce cardiovascular risk in adults with heart disease and either obesity or overweight

Each individual's body is unique, and these injections can be tailored to address speci fi c areas of concern